Skip to content

    Digestive Health Clinical Trials

    "NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED, SINGLE-BLIND, SHAM-CONTROLLED CROSSOVER STUDY"

    Learn more

    What is the purpose of this study?

    Randomized, single-blind, sham-controlled crossover study evaluating the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in adult patients with IBS. Two intervention groups will receive the investigational NurosymTM device and be randomized (1:1) to either the ACTIVE or SHAM crossover taVNS group. After randomization, participants will receive 8 weeks of active stimulation (ACTIVE) or 4 weeks of sham followed by 4 weeks of active stimulation (SHAM crossover).

    Eligibility

    1. Male and female adults, aged 18 to 60 years, who can provide written, informed consent.

    2. A diagnosis of IBS according to Rome IV criteria, as follows:

      a. Recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, associated with 2 or more of the following criteria: i. Related to defecation. ii. Associated with a change in stool frequency. iii. Associated with a change in stool from (appearance). b. Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis.

    3. Completion of at least 4 of the 7 daily surveys during week prior to study intervention

    4. Average daily abdominal intensity score between 4 and 8 (on a 10-point numeric rating scale) during week prior to study intervention.

    5. Ability to read and speak English fluently.

    6. Ability to provide own written informed consent (or assent) and comply with the requirements of the study.

    7. Daily access to a computer with internet for online surveys

    Where can I participate?

    Hoag Hospital Irvine
    16200 Sand Canyon Ave
    Irvine, CA 92618


    Vianh Truong

    vianh.truong@hoag.org


    Hoag Hospital Newport Beach
    1 Hoag
    Newport Beach, CA 92663


    Vianh Truong

    vianh.truong@hoag.org


    More about this Clinical Trial

    What is the full name of this Clinical Trial?

    NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED, SINGLE-BLIND, SHAM-CONTROLLED CROSSOVER STUDY

    • Disease Type/ConditionIrritable Bowel Syndrome (IBS)
    • Principal InvestigatorCatherine Ngo
    • Age GroupAdult
    • PhaseN/A
    • ClinicalTrials.gov IDNCT07890948

    Hoag Digestive Health Institute

    Hoag Digestive Health Institute provides advanced, comprehensive care for the full spectrum of digestive conditions, with access to world-class specialists, diagnostics and imaging, advanced interventional therapeutics, and clinical trials. Patients benefit from a research-driven approach that connects leading-edge treatment options with personalized care across gastroenterology and GI surgery.

    Learn More
    Dr. Grossman in a white coat writing on a board

    Stay up-to-date on the latest news from Hoag

    By submitting this request, you agree to receive communications from Hoag and accept our Privacy Policy and Terms of Use.